1978.5000 -86.30 (-4.18%)
NSE Aug 01, 2025 15:31 PM
Volume: 167.7K
 

1978.50
-4.18%
Axis Direct
China remains a key geographic focus area for the company. Gland has received and launched one product this year. Recommendation: HOLD
Gland Pharma Ltd. has gained 40.97% in the last 3 Months
More from Gland Pharma Ltd.
Recommended